Multiple mouse models of primary lymphedema exhibit distinct defects in lymphovenous valve development

Developmental Biology

Volumn 409, Issue 1, 2016, Pages 218-233

  Geng, Xin ^a   Cha, Boksik ^a   Mahamud, Md Riaj ^a   Lim, Kim Chew ^c   Silasi Mansat, Robert ^a   Uddin, Mohammad K M ^d   Miura, Naoyuki ^d   Xia, Lijun ^a   Simon, Alexander M ^e   Engel, James Douglas ^c   Chen, Hong ^a   Lupu, Florea ^a   Srinivasan, R Sathish ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; ENDOTHELIUM CELL; LYMPH; LYMPH FLOW; LYMPHATIC ENDOTHELIAL CELL; LYMPHEDEMA; LYMPHOVENOUS VALVE; MORPHOGENESIS; MOUSE; NEWBORN; NONHUMAN; PERICYTE; PRIMARY LYMPHEDEMA; PRIORITY JOURNAL; VEIN VALVE; ANIMAL; C57BL MOUSE; DISEASE MODEL; EMBRYOLOGY; LYMPH VESSEL; PATHOLOGY; PENETRANCE; PHENOTYPE; ULTRASTRUCTURE;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; LYMPHATIC VESSELS; LYMPHEDEMA; MICE, INBRED C57BL; MORPHOGENESIS; PENETRANCE; PHENOTYPE; VENOUS VALVES;

EID: 84958566099     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2015.10.022     Document Type: Article

References (52)

1. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell. Biol. 2007, 8:464-478.
2. Armstrong E.J., Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 2004, 95:459-470.
3. Armulik A., Genove G., Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell. 2011, 21:193-215.
4. Bazigou E., Lyons O.T., Smith A., Venn G.E., Cope C., Brown N.A., Makinen T. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J. Clin. Investig. 2011, 121:2984-2992.
5. Bazigou E., Xie S., Chen C., Weston A., Miura N., Sorokin L., Adams R., Muro A.F., Sheppard D., Makinen T. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev. Cell. 2009, 17:175-186.
6. Bertozzi C.C., Schmaier A.A., Mericko P., Hess P.R., Zou Z., Chen M., Chen C.Y., Xu B., Lu M.M., Zhou D., et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 2010, 116:661-670.
7. Bowles J., Secker G., Nguyen C., Kazenwadel J., Truong V., Frampton E., Curtis C., Skoczylas R., Davidson T.L., Miura N., et al. Control of retinoid levels by CYP26B1 is important for lymphatic vascular development in the mouse embryo. Dev. Biol. 2014, 386:25-33.
8. Chang C.P., Neilson J.R., Bayle J.H., Gestwicki J.E., Kuo A., Stankunas K., Graef I.A., Crabtree G.R. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell 2004, 118:649-663.
9. Chen H., Griffin C., Xia L., Srinivasan R.S. Molecular and cellular mechanisms of lymphatic vascular maturation. Microvasc. Res. 2014, 96:16-22.
10. Coxam B., Sabine A., Bower N.I., Smith K.A., Pichol-Thievend C., Skoczylas R., Astin J.W., Frampton E., Jaquet M., Crosier P.S., et al. Pkd1 regulates lymphatic vascular morphogenesis during development. Cell. Reports 2014, 7:623-633.
11. Francois M., Caprini A., Hosking B., Orsenigo F., Wilhelm D., Browne C., Paavonen K., Karnezis T., Shayan R., Downes M., et al. Sox18 induces development of the lymphatic vasculature in mice. Nature 2008, 456:643-647.
12. Francois M., Short K., Secker G.A., Combes A., Schwarz Q., Davidson T.L., Smyth I., Hong Y.K., Harvey N.L., Koopman P. Segmental territories along the cardinal veins generate lymph sacs via a ballooning mechanism during embryonic lymphangiogenesis in mice. Dev. Biol. 2012, 364:89-98.
13. Fu J., Gerhardt H., McDaniel J.M., Xia B., Liu X., Ivanciu L., Ny A., Hermans K., Silasi-Mansat R., McGee S., et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J. Clin. Investig. 2008, 118:3725-3737.
14. Furumoto T.A., Miura N., Akasaka T., Mizutani-Koseki Y., Sudo H., Fukuda K., Maekawa M., Yuasa S., Fu Y., Moriya H., et al. Notochord-dependent expression of MFH1 and PAX1 cooperates to maintain the proliferation of sclerotome cells during the vertebral column development. Dev. Biol. 1999, 210:15-29.
15. Hagerling R., Pollmann C., Kremer L., Andresen V., Kiefer F. Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse. Biochem. Soc. Trans. 2011, 39:1674-1681.
16. Hess P.R., Rawnsley D.R., Jakus Z., Yang Y., Sweet D.T., Fu J., Herzog B., Lu M., Nieswandt B., Oliver G., et al. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. J. Clin. Investig. 2014, 124:273-284.
17. Hong Y.K., Harvey N., Noh Y.H., Schacht V., Hirakawa S., Detmar M., Oliver G. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 2002, 225:351-357.
18. Iida K., Koseki H., Kakinuma H., Kato N., Mizutani-Koseki Y., Ohuchi H., Yoshioka H., Noji S., Kawamura K., Kataoka Y., et al. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 1997, 124:4627-4638.
19. Kanady J.D., Dellinger M.T., Munger S.J., Witte M.H., Simon A.M. Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev. Biol. 2011, 354:253-266.
20. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 2004, 5:74-80.
21. Kazenwadel J., Betterman K.L., Chong C.E., Stokes P.H., Lee Y.K., Secker G.A., Agalarov Y., Demir C.S., Lawrence D.M., Sutton D.L., et al. GATA2 is required for lymphatic vessel valve development and maintenance. J. Clin. Investig. 2015.
22. Kazenwadel J., Secker G.A., Liu Y.J., Rosenfeld J.A., Wildin R.S., Cuellar-Rodriguez J., Hsu A.P., Dyack S., Fernandez C.V., Chong C.E., et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 2012, 119:1283-1291.
23. Khandekar M., Brandt W., Zhou Y., Dagenais S., Glover T.W., Suzuki N., Shimizu R., Yamamoto M., Lim K.C., Engel J.D. A Gata2 intronic enhancer confers its pan-endothelia-specific regulation. Development 2007, 134:1703-1712.
24. Klein K.R., Karpinich N.O., Espenschied S.T., Willcockson H.H., Dunworth W.P., Hoopes S.L., Kushner E.J., Bautch V.L., Caron K.M. Decoy receptor CXCR7 modulates adrenomedullin-mediated cardiac and lymphatic vascular development. Dev. Cell. 2014, 30:528-540.
25. Lim K.C., Hosoya T., Brandt W., Ku C.J., Hosoya-Ohmura S., Camper S.A., Yamamoto M., Engel J.D. Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J. Clin. Investig. 2012, 122:3705-3717.
26. Majesky M.W., Dong X.R., Regan J.N., Hoglund V.J. Vascular smooth muscle progenitor cells: building and repairing blood vessels. Circ. Res. 2011, 108:365-377.
27. Makinen T., Adams R.H., Bailey J., Lu Q., Ziemiecki A., Alitalo K., Klein R., Wilkinson G.A. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes. Dev. 2005, 19:397-410.
28. Munger S.J., Kanady J.D., Simon A.M. Absence of venous valves in mice lacking Connexin37. Dev. Biol. 2013, 373:338-348.
29. Norrmen C., Ivanov K.I., Cheng J., Zangger N., Delorenzi M., Jaquet M., Miura N., Puolakkainen P., Horsley V., Hu J., et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell. Biol. 2009, 185:439-457.
30. Ostergaard P., Simpson M.A., Connell F.C., Steward C.G., Brice G., Woollard W.J., Dafou D., Kilo T., Smithson S., Lunt P., et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet. 2011, 43:929-931.
31. Outeda P., Huso D.L., Fisher S.A., Halushka M.K., Kim H., Qian F., Germino G.G., Watnick T. Polycystin signaling is required for directed endothelial cell migration and lymphatic development. Cell. Reports 2014, 7:634-644.
32. Petrova T.V., Karpanen T., Norrmen C., Mellor R., Tamakoshi T., Finegold D., Ferrell R., Kerjaschki D., Mortimer P., Yla-Herttuala S., et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 2004, 10:974-981.
33. Petrova T.V., Makinen T., Makela T.P., Saarela J., Virtanen I., Ferrell R.E., Finegold D.N., Kerjaschki D., Yla-Herttuala S., Alitalo K. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 2002, 21:4593-4599.
34. Phan S.H. The myofibroblast in pulmonary fibrosis. Chest 2002, 122:286S-289S.
35. Potapova T.A., Sivakumar S., Flynn J.N., Li R., Gorbsky G.J. Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited. Mol. Biol. Cell. 2011, 22:1191-1206.
36. Raymond C.S., Soriano P. High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLOS One 2007, 2:e162.
37. Sabine A., Agalarov Y., Maby-El Hajjami H., Jaquet M., Hagerling R., Pollmann C., Bebber D., Pfenniger A., Miura N., Dormond O., et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev. Cell. 2012, 22:430-445.
38. Seeger M., Bewig B., Gunther R., Schafmayer C., Vollnberg B., Rubin D., Hoell C., Schreiber S., Folsch U.R., Hampe J. Terminal part of thoracic duct: high-resolution US imaging. Radiology 2009, 252:897-904.
39. Seo S., Kume T. Forkhead transcription factors, Foxc1 and Foxc2, are required for the morphogenesis of the cardiac outflow tract. Dev. Biol. 2006, 296:421-436.
40. Simon A.M., Goodenough D.A., Li E., Paul D.L. Female infertility in mice lacking connexin 37. Nature 1997, 385:525-529.
41. Srinivasan R.S., Dillard M.E., Lagutin O.V., Lin F.J., Tsai S., Tsai M.J., Samokhvalov I.M., Oliver G. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes. Dev. 2007, 21:2422-2432.
42. Srinivasan R.S., Escobedo N., Yang Y., Interiano A., Dillard M.E., Finkelstein D., Mukatira S., Gil H.J., Nurmi H., Alitalo K., et al. The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes. Dev. 2014, 28:2175-2187.
43. Srinivasan R.S., Geng X., Yang Y., Wang Y., Mukatira S., Studer M., Porto M.P., Lagutin O., Oliver G. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes. Dev. 2010, 24:696-707.
44. Srinivasan R.S., Oliver G. Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves. Genes. Dev. 2011, 25:2187-2197.
45. Tammela T., Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010, 140:460-476.
46. Tatin F., Taddei A., Weston A., Fuchs E., Devenport D., Tissir F., Makinen T. Planar cell polarity protein Celsr1 regulates endothelial adherens junctions and directed cell rearrangements during valve morphogenesis. Dev. Cell. 2013, 26:31-44.
47. Truman L.A., Bentley K.L., Smith E.C., Massaro S.A., Gonzalez D.G., Haberman A.M., Hill M., Jones D., Min W., Krause D.S., et al. ProxTom lymphatic vessel reporter mice reveal Prox1 expression in the adrenal medulla, megakaryocytes, and platelets. Am. J. Pathol. 2012, 180:1715-1725.
48. Tsai F.Y., Keller G., Kuo F.C., Weiss M., Chen J., Rosenblatt M., Alt F.W., Orkin S.H. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994, 371:221-226.
49. Turner C.J., Badu-Nkansah K., Crowley D., van der Flier A., Hynes R.O. Integrin-alpha5beta1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation and lymphovenous valve formation. Dev. Biol. 2014, 392:381-392.
50. Uhrin P., Zaujec J., Breuss J.M., Olcaydu D., Chrenek P., Stockinger H., Fuertbauer E., Moser M., Haiko P., Fassler R., et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010, 115:3997-4005.
51. Wigle J.T., Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999, 98:769-778.
52. Yang Y., Garcia-Verdugo J.M., Soriano-Navarro M., Srinivasan R.S., Scallan J.P., Singh M.K., Epstein J.A., Oliver G. Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos. Blood 2012, 120:2340-2348.